复星医药(02196.HK)与智翔金泰(688443.SH)签战略合作框架协议

阿斯达克财经
May 29

复星医药(02196.HK) 宣布,与智翔金泰(688443.SH) 正式签署战略合作框架协议。双方将通过建立长期、稳定、互信的战略合作伙伴关系,加速创新药物的研发与商业化进程,共同提升双方的核心竞争力和行业影响力。作为本次战略合作的首个落地成果,复星医药控股子公司药友制药与智翔金泰就许可产品,即以纬利妥米单抗(GR1803)为唯一活性成分及/或约定的同时靶向BCMA和CD3的双特异性抗体药品达成...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10